Livzon Pharmaceutical Group Inc
SZSE:000513

Watchlist Manager
Livzon Pharmaceutical Group Inc Logo
Livzon Pharmaceutical Group Inc
SZSE:000513
Watchlist
Price: 34.78 CNY -0.51%
Market Cap: 31.7B CNY

Livzon Pharmaceutical Group Inc's latest stock split occurred on Jul 3, 2019

The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.

Before the split, Livzon Pharmaceutical Group Inc traded at 26.6462 per share. Afterward, the share price was about 22.91.

The adjusted shares began trading on Jul 3, 2019. This was Livzon Pharmaceutical Group Inc's 7th stock split, following the previous one in Jun 22, 2018.

Last Splits:
Jul 3, 2019
1-for-1
Jun 22, 2018
1-for-1
Jul 7, 2017
13-for-10
Aug 14, 2015
13-for-10
Dec 11, 2006
11-for-10
Pre-Split Price
23.3948 26.6462
Post-Split Price
22.91
Before
After
Last Splits:
Jul 3, 2019
1-for-1
Jun 22, 2018
1-for-1
Jul 7, 2017
13-for-10
Aug 14, 2015
13-for-10
Dec 11, 2006
11-for-10

Livzon Pharmaceutical Group Inc
Stock Splits History

Livzon Pharmaceutical Group Inc Stock Splits Timeline
Jul 3, 2019
Jul 3, 2019
Split 1-for-1
/1
Pre-Split Price
23.3948 26.6462
Post-Split Price
22.91
Before
After
Jun 22, 2018
Jun 22, 2018
Split 1-for-1
/1
Pre-Split Price
32.8386 38.5858
Post-Split Price
31.9652
Before
After
Jul 7, 2017
Jul 7, 2017
Split 13-for-10
x1.3
Pre-Split Price
25.6401 39.4616
Post-Split Price
25.1539
Before
After
Aug 14, 2015
Aug 14, 2015
Split 13-for-10
x1.3
Pre-Split Price
20.2641 41.0947
Post-Split Price
18.2439
Before
After
Dec 11, 2006
Dec 11, 2006
Split 11-for-10
x1.1
Pre-Split Price
N/A
Post-Split Price
6.7405
Before
After
Sep 4, 1997
Sep 4, 1997
Split 1-for-1
/1
Pre-Split Price
N/A
Post-Split Price
6.7405
Before
After
May 26, 1994
May 26, 1994
Split 1-for-1
/1
Pre-Split Price
N/A
Post-Split Price
6.7405
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2025
Seres Therapeutics Inc
SWB:1S9
1-for-20
/20
0.3216 6.432 EUR 6.432 6.432 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
F:4LE0
1-for-10
/10
0.011 0.11 EUR 0.11 0.11 EUR
Apr 22, 2025
E
EV Advanced Material Co Ltd
KOSDAQ:131400
911-for-787
x1.1575603557814
1493 1493 KRW 1439 1439 KRW
Apr 22, 2025
Seres Therapeutics Inc
F:1S9
1-for-20
/20
0.01 0.2 EUR 0.2 0.2 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
OTC:GSRFF
1-for-10
/10
0.024 0.24 USD 0.24 0.24 USD
Load More

Livzon Pharmaceutical Group Inc
Glance View

Market Cap
31.4B CNY
Industry
Pharmaceuticals

Nestled within the bustling pharmaceutical landscape of China, Livzon Pharmaceutical Group Inc. has meticulously carved its path since its inception in 1985, blossoming into a formidable player in the industry. Based in Zhuhai, Guangdong Province, the company has steadily built a diversified portfolio across the pharmaceutical spectrum, focusing on both traditional Chinese medicine and modern biopharmaceutical products. Livzon leverages its robust research and development (R&D) capabilities to produce an extensive range of medications, catering primarily to major therapeutic areas such as cardiovascular, gastrointestinal, anti-infective, and oncology segments. With rigorous standards driving their production lines, they ensure premium quality, which has bolstered their reputation and allowed them to secure numerous patents and proprietary products. Livzon's revenue engine is fueled by its strategic blend of manufacturing prowess and a well-tuned distribution network. The company operates a comprehensive production chain, from raw material sourcing and pharmaceuticals manufacturing to extensive distribution channels stretching across domestic and global markets. It sustains strong collaborations with hospitals, medical institutions, and pharmacies, which facilitate widespread accessibility and market penetration. Additionally, Livzon invests heavily in innovation, aligning with global health demands through strategic partnerships and joint ventures, further pushing the boundaries of research. By balancing traditional medicinal wisdom with cutting-edge technologies, Livzon positions itself as an agile competitor in the ever-evolving pharmaceutical arena, continuously driving value creation and securing its foothold in the global marketplace.

Intrinsic Value
46.53 CNY
Undervaluation 25%
Intrinsic Value
Price
Back to Top